SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-242526
Filing Date
2023-09-26
Accepted
2023-09-26 16:31:01
Documents
14
Period of Report
2023-09-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d548878d8k.htm   iXBRL 8-K 25635
2 EX-99.1 d548878dex991.htm EX-99.1 83637
6 GRAPHIC g548878g0926093226671.jpg GRAPHIC 3720
  Complete submission text file 0001193125-23-242526.txt   248608

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA meip-20230926.xsd EX-101.SCH 2857
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE meip-20230926_lab.xml EX-101.LAB 17995
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meip-20230926_pre.xml EX-101.PRE 11266
8 EXTRACTED XBRL INSTANCE DOCUMENT d548878d8k_htm.xml XML 3342
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 231280828
SIC: 2834 Pharmaceutical Preparations